SCHEMBL10132266

SCHEMBL10132266

COc1cc2c(ccc3c4ccc5c(c4c[n+](C)c23)OCO5)c(Cc2ccccc2)c1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.51
▸ BAD Q92934 7/20 0.51
▸ HPGD P15428 7/20 0.51
▸ SMN1; SMN2 Q16637 7/20 0.51
▸ KDM4E B2RXH2 6/20 0.51
▸ MAPT P10636 5/20 0.51
▸ MAPK1 P28482 5/20 0.51
▸ KMT2A Q03164 4/20 0.51
▸ ACHE P22303 4/20 0.51
▸ MEN1 O00255 3/20 0.51
▸ LMNA P02545 3/20 0.51
▸ BCHE P06276 3/20 0.51
▸ TP53 P04637 3/20 0.51
▸ CYP3A4 P08684 3/20 0.51
▸ ALOX15 P16050 3/20 0.51
▸ ALOX12 P18054 3/20 0.51
▸ HSD17B10 Q99714 3/20 0.51
▸ HTT P42858 3/20 0.51
▸ RGS17 Q9UGC6 2/20 0.51
▸ NPC1 O15118 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10132359 0.85 BAD (0.61) ALDH1A1BADHPGDSMN1; SMN2KDM4E
SCHEMBL10132268 0.84 BAD (0.53) ALDH1A1BADHPGDSMN1; SMN2KDM4E
SCHEMBL10132270 0.83 BAD (0.51) ALDH1A1BADHPGDSMN1; SMN2KDM4E
Hydrochloric Acid SCHEMBL423231 0.82 ALDH1A1 (0.52) ALDH1A1BADHPGDSMN1; SMN2KDM4E
SCHEMBL10132397 0.81 RAC1 (0.43) ALDH1A1BADHPGDSMN1; SMN2KDM4E
SCHEMBL10132352 0.79 BAD (0.65) ALDH1A1BADHPGDSMN1; SMN2KDM4E
SCHEMBL13284358 0.78 ALDH1A1 (0.67) ALDH1A1BADHPGDSMN1; SMN2KDM4E
SCHEMBL10132265 0.78 ALDH1A1 (0.52) ALDH1A1BADHPGDSMN1; SMN2KDM4E
SCHEMBL10132288 0.77 BAD (0.51) ALDH1A1BADHPGDSMN1; SMN2KDM4E
SCHEMBL10132560 0.77 BAD (0.76) ALDH1A1BADHPGDSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 — — US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 — — US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS CCNT1, XPO4, XDH ALDH1A1 3095/4885BAD 384/4885HPGD 1643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback